维普期刊资源整合服务平台（V6.5）

62篇 您的检索式：作者名="Gulberg"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Evaluation of serum Cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver显示文摘	Gerbes AL Gulberg V Bilzer M		0，，：	1
2	Simple sequence repeat(SSR)marker survey of the cassava(Manihot esculenta Crantz)genome:toward a SSR-based molecular genetic map of cassava显示文摘	Mba R E C Stephenson P Edwards K Mezer S Nkumbira J Gulberg U Apel K Gale M Tohme J Fregene M A		0，，：	1
3	Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver显示文摘	Gerbes A L Gulberg V Bilzer M	2002	Gut2002，50，1：	1
4	Longevity in patients with high degree atrioventricular blockpaced in the atrial synchronous or the fixed rate ventricular inhibited mode显示文摘	Linde-Edelstam C Gulberg B Nordlander R	1992	PACE1992，15，3：	1
5	Long-term therapy and retreatment of hepatorenal syndrome type I with ornipressin and opamine显示文摘	Gulberg V Bilzer M C erbes AL	1999	Hepatology1999，30，4：	1
6	Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure 显示文摘	Gulberg V Moiler S Henriksen JH	2000	Gut2000，47，6：	1
7	Submillimeter emission from optically pumped NH3 显示文摘	GULBERG K HARTMAN B KLEMAN B	1973	Phys Scripta1973，8，1：	1
8	Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist:a randomized double-blind multicenter trial显示文摘	Gerbes AL Gulberg V Gines P	2003	Gastroenterology2003，124，4：	1
9	Evaluation of serum cystatin C coneentration as a marker of rnal function inpatients with cirrhosis of the oiver显示文摘	Gerbes AL Gulberg V Bilzer M	2002	Gut2002，50，50：	1
10	Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems显示文摘	Bernardi M Gulberg V Colantoni A	1996	J Hepatol1996，24，9：	1
11	Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial显示文摘	GERBES AL GULBERG V GINES P	2003	Gastroenterology2003，124，4：	1
12	Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: Effects in patients with organic or functional renal failure显示文摘	Michl P Gulberg V Bilzer M	2000	Scand J Gastroenterol2000，35，6：	1
13	Long-termtherapy and reteratment of hepatorenal syndrome type Ⅰ with ornipressin and dopamine显示文摘	GULBERG V BILZER M GERBESAL	1999	Hepatology1999，30，4：	1
14	Improved quality of life in patients with refractory or recidivant ascites after insertion of transjugular intrahepatic portosystemic shunts显示文摘	Gulberg V Liss I Bilzer M	2002	Digestion2002，66，2：	1
15	A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites显示文摘	Rossle M Ochs A Gulberg V	2000	N Engl J Med2000，342，23：	1
16	A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites显示文摘	Rossle M Ochs A Gulberg V	2000	N Engl J Med2000，342，：	1
17	Endothelin-1 and Endothelin-3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function 显示文摘	Gerbes AL Moiler S Gulberg V	1995	Hepatology1995，21，3：	1
18	Q-T interval (QT(C)) in patients with cirrhosis:relation to vasoactive peptides and heart rate显示文摘	HENRIKSEN J H GULBERG V FUGLSANG S	2007	Scand J Clin Lab Invest2007，67，6：	1
19	Endothelin-1 and endothelin-3 in cirrhosis:relations to systemic and splanchnil haemo-dynamics显示文摘	Moller S Gulberg Henriksen JH	1995	Hepatol1995，23，2：	1
20	A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites显示文摘	Rossle M Ochs A Gulberg V	2000	N Engl J Med2000，342，23：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示